Oxycontin Patent Expiring in Canada. Now What?

In Canada, just like the United States, there is an addiction epidemic currently being fought by communities and the government. Lawsuits against drug makers are also underway. Purdue Pharma, the original manufacturer of Oxycontin, is largely blamed for the opioid epidemic. Their patent in Canada is expiring, leaving the market open to cheaper, generic versions of the drug. Why Allow More Opioids on the Market? Many people argue that there should be no more Oxycontin on the market period. The drug has caused devastation across North America. Purdue Pharma certainly pushed the drug deceptively. An opioid maker without such a checkered past would be a welcome relief to sales representatives and hospitals. But a generic version would also create more opportunities for misuse and abuse. Can a regulatory body police the actions of addictive drugs effectively? There are a lot of misgivings about the benefits of offering a generic version of Oxy. The truth of the matter is that there are thousands of people in hospital rooms that need…

Continue Reading

Canadian Coroner Offers Words of Warning about OxyNEO

A recent article from CBC News out of Canada caught our eye and we wanted to share. A coroner has made a statement to health care professionals in Canada warning them that OxyContin replacement drugs (like OxyNEO) are still very dangerous and increased caution should be used in prescribing them. His statement comes as a result of an opiate overdose and in his words: “Transitioning from one opiate to another does carry some risks, and this death … highlighted the case for heightened vigilance,” Wilson said. Users May Subconsciously Seek Higher Doses of OxyNEO Wilson wanted to highlight the dangers that are inherent in switching drugs.  Many users who are not happy with the sensation of OxyNEO (or another OxyContin replacement like OxyIR or fentanyl) might prescribing physicians to clarify any questionable increases in dosage. Dr. Wilson encourages  pharmacists to screen prescriptions for patterns indicating increased dosages and to contact prescribing physicians to clarify any change. Dr. Wilson has also requested other coroners to be on alert for similar deaths.…

Continue Reading

New Drugs Same Old Problem – OxyNEO Zohydro Oxecta Etc

There is a lot of controversy brewing about the new drugs that are coming to market. "Tamper Proof" OxyContin An example is "harder to abuse" drugs: like OxyNEO. The question is, how "hard to abuse" are they? There are critics who point out that the drug's manufacturer Purdue Pharma doesn't make that claim in official documents. Additionally “The terms ‘tamper-proof’ and ‘break-proof’ are not claims which have been approved by Health Canada,” admits Randy Steffan who is vice president of corporate affairs at Purdue Pharma. Pfizer has joined the "profit (off of addictive drugs) party" with its Oxecta drug, which is made from the highly addictive ingredient in OxyContin called oxycodone. It is purported to be difficult to "Pure" Hydrocodone (or Vicodin) In a move that baffles the sense of corporate responsibility, there are multiple drug manufacturers planning to release a form of Vicodin that is made up of pure hydrocodone (the addictive painkiller ingredient in Vicodin). Zohydro is one name for the drug, and there are multiple entities…

Continue Reading

Canada Takes Desperate Action Against OxyContin Addiction

The government of Canada is taking strong measures to stem the tide of OxyContin abuse. At the end of this month, the pharmaceutical company that produces OxyContin will no longer be allowed to manufacture and market the drug in Canada. Under government pressure, Purdue Pharma Canada is replacing OxyContin with a new formulation called OxyNEO. According to Purdue, the design of OxyNEO will make it more difficult to abuse. OxyContin is a time-released version of oxycodone, a highly addictive opioid painkiller. It has been described by drug experts as being twice as strong as morphine. When the time-released pills are crushed and injected or inhaled or chewed, OxyContin produces a high that has been compared to heroin. While OxyNEO will still contain oxycodone, Purdue claims that it will be harder to crush and will form a thick get that resists injection when added to liquid. Entire Communities Impacted The media in Canada has recently focused on the plight of First Nations native people living on impoverished reserves in the…

Continue Reading

Dedicated to OxyNEO Drug Awareness

OxyNEO Drug Rehab is here to bring awareness to the phenomenon of prescription drug addiction and overdose. We are a group of addictions industry professionals who feel that the spectre of OxyContin will not be alleviated by the new formulation called OxyNEO.  Purdue Pharma has already released a "tamper proof" version of the drug OxyContin and  this has not really alleviated the "silent epidemic" of opiate addiction that OxyContin has become the poster child for.  To be fair, both tamper proof OxyContin and (most likely) OxyNEO are steps in the right direction and we appreciate that Purdue Pharma is addressing the issue (even if their executives are facing prison sentences for the unethical promotion of OxyContin which began in 1996). A Very Serious Epidemic of Addiction and Overdose OxyContin and OxyNEO are only part of a larger problem.  This is a problem that has radically affected millions of lives across all social strata in the United States (and certainly beyond).  The problem is that prescription drugs like OxyNEO are…

Continue Reading